U.S. Markets open in 1 hr 41 mins

Repros Therapeutics Inc. (RPRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2995+0.0001 (+0.0334%)
At close: 3:59PM EDT
People also watch
SNSSTHLDOPXACYCCOGXI
Full screen
Previous Close0.2994
Open0.3000
Bid0.2800 x 100
Ask0.4900 x 40000
Day's Range0.2830 - 0.3200
52 Week Range0.2830 - 0.3500
Volume540,489
Avg. Volume204,400
Market Cap11.05M
Beta0.31
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Trade prices are not sourced from all markets
  • Associated Press2 days ago

    Repros Therapeutics reports 2Q loss

    The The Woodlands, Texas-based company said it had a loss of 8 cents per share. The biopharmaceutical company posted revenue of $7,000 in the period. The company's shares closed at 35 cents. A year ago, ...

  • GlobeNewswire3 days ago

    Repros Therapeutics Inc.® Reports Second Quarter 2017 Financial Results

    THE WOODLANDS, Texas, Aug. 14, 2017-- Repros Therapeutics Inc. ® today announced financial results for the second quarter ended June 30, 2017.. Net loss for the three month period ended June 30, 2017, ...

  • Repros (RPRX) Q2 Earnings: What's in Store for the Stock?
    Zacks16 days ago

    Repros (RPRX) Q2 Earnings: What's in Store for the Stock?

    Lack of revenues in Repros Therapeutics' (RPRX) product portfolio could be a concern. But the company's most advanced pipeline candidates -- enclomiphene and Proellex -- might better its results in Q2.